Most Read Articles
Pearl Toh, 10 Oct 2019
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
2 days ago
Environmental quality and exposure to pollution may play a small part in the development of metabolic diseases, such as diabetes, a new study has found.
Tristan Manalac, 4 days ago
Sleep deprivation impairs adolescents’ long-term retention of classroom material, according to a recent Singapore study.
6 days ago
Eating alone may help in weight management as findings of a recent study suggest that eating with friends lead to higher food intake.

Long-acting opioid tied to increased risk of serious infections

07 Oct 2018

Patients using long-acting opioids with immunosuppressive properties are at greater risk of developing serious infections compared with those using the nonimmunosuppressive opioid counterpart, according to a study.

The study involved Tennessee Medicaid adult enrolees initiating long-acting opioids for pain. Infection risk was compared between individuals using long-acting opioids with known immunosuppressive properties (eg, morphine, fentanyl and methadone; n=61,240) and those using long-acting opioids without immunosuppressive properties (eg, oxycodone, oxymorphone and tramadol; n=22,811).

A total of 1,906 serious infections were identified during 55,663 person-years of follow-up (3.42 hospitalizations for serious infections per 100 person-years). The most common infection was pneumonia (56.1 percent), followed by cellulitis (17.9 percent), bacteraemia without pneumonia (15.3 percent), pyelonephritis (6.1 percent) and septic arthritis/osteomyelitis (3.8 percent).

Multivariate Poisson regression models showed that compared with nonimmunosuppressive opioid users, individuals using immunosuppressive opioids had a lower rate of serious infections (adjusted incidence rate ratio [aIRR], 0.78; 95 percent CI, 0.66–0.91).

Among individual opioids, oxycodone yielded the lowest risk of infection (aIRR, 0.73; 0.61–0.89). No significant differences in the infection risk were observed among other opioids and morphine.

The present data are consistent with results from animal and in-vitro experimental studies showing immunosuppressive properties only in certain opioids, researchers said. It is therefore important to carefully consider the risk of serious infections when making pain management decisions.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 10 Oct 2019
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
2 days ago
Environmental quality and exposure to pollution may play a small part in the development of metabolic diseases, such as diabetes, a new study has found.
Tristan Manalac, 4 days ago
Sleep deprivation impairs adolescents’ long-term retention of classroom material, according to a recent Singapore study.
6 days ago
Eating alone may help in weight management as findings of a recent study suggest that eating with friends lead to higher food intake.